Cargando…

Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stenting

A sizable proportion of coronary artery disease (CAD) patients undergoing percutaneous coronary intervention (PCI) with stent implantation have an indication for treatment with oral anticoagulant therapy (OAC). The coexistence of atrial fibrillation (AF) and the need for PCI expose patients to a hig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buccheri, Sergio, Angiolillo, Dominick J., Capodanno, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902384/ https://www.ncbi.nlm.nih.gov/pubmed/31814532 http://dx.doi.org/10.1177/1753944719891688

Ejemplares similares

Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis
por: Capodanno, Davide, et al.
Publicado: (2020)

Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management
por: Ortega‐Paz, Luis, et al.
Publicado: (2021)

Bioabsorbable stents: only bad news?
por: Buccheri, Sergio, et al.
Publicado: (2019)

Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use
por: Capodanno, Davide, et al.
Publicado: (2019)

Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions
por: Galli, Mattia, et al.
Publicado: (2023)

Optimum Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation and Undergoing Percutaneous Coronary Intervention
por: Agarwal, Nayan, et al.
Publicado: (2018)

Platelet thrombin receptor antagonism and atherothrombosis
por: Angiolillo, Dominick J., et al.
Publicado: (2010)

When Less Becomes More: Insights on the Pharmacodynamic Effects of Aspirin Withdrawal in Patients With Potent Platelet P2Y(12) Inhibition Induced by Ticagrelor
por: Capodanno, Davide, et al.
Publicado: (2020)

Patient-tailored antithrombotic therapy following percutaneous coronary intervention
por: van der Sangen, Niels M R, et al.
Publicado: (2021)

Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis
por: Menozzi, Mila, et al.
Publicado: (2012)

Antithrombotic Management in AF Patients Following Percutaneous Coronary Intervention: A European Perspective
por: Greco, Antonio, et al.
Publicado: (2023)

The Role of Antiplatelet Therapy in Patients With MINOCA
por: Ortega-Paz, Luis, et al.
Publicado: (2022)

Antithrombotic therapy in diabetes: which, when, and for how long?
por: Ajjan, Ramzi A, et al.
Publicado: (2021)

Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestations
por: Cho, Sung Won, et al.
Publicado: (2019)

Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation
por: Zalewski, Jarosław, et al.
Publicado: (2016)

The New Oral Anticoagulants for the Treatment of Venous Thromboembolism: A New Paradigm Shift in Antithrombotic Therapy
por: Galanis, Taki, et al.
Publicado: (2014)

Novel drug-eluting stents in the treatment of de novo coronary lesions
por: Capodanno, Davide, et al.
Publicado: (2011)

Tailoring P2Y(12) Inhibiting Therapy in Elderly Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Capranzano, Piera, et al.
Publicado: (2019)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
por: Pham, Son V, et al.
Publicado: (2010)

Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
por: Bonanad, Clara, et al.
Publicado: (2022)

Shortening Dual Antiplatelet Therapy Duration in High-Risk Patients Undergoing Percutaneous Coronary Intervention
por: Greco, Antonio, et al.
Publicado: (2023)

Evolving Paradigms in Melanoma Therapy
por: Olszanski, Anthony J., et al.
Publicado: (2016)

ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes
por: De Luca, Leonardo, et al.
Publicado: (2022)

A new paradigm shift in antithrombotic therapy
por: Pudusseri, Anita, et al.
Publicado: (2013)

Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
por: Kwak, Soongu, et al.
Publicado: (2019)

Atrial fibrillation patients undergoing percutaneous coronary intervention: dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulants
por: Goette, Andreas, et al.
Publicado: (2020)

In-hospital antithrombotic therapy and outcomes of elderly patients on warfarin undergoing percutaneous coronary intervention: Insights from the WAR-STENT registry
por: Zagnoni, Silvia, et al.
Publicado: (2022)

Long-term monotherapy with ticagrelor after coronary stenting: the GLOBAL LEADERS study
por: Greco, Antonio, et al.
Publicado: (2020)

Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study
por: De Luca, Leonardo, et al.
Publicado: (2020)

Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
por: Parikh, Shailja V, et al.
Publicado: (2009)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
por: De Luca, Leonardo, et al.
Publicado: (2022)

Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world Study
por: Kebernik, Julia, et al.
Publicado: (2018)

Novel Dual Therapy: A Paradigm Shift in Anticoagulation in Patients of Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Pradhan, Akshyaya, et al.
Publicado: (2020)

Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives
por: De Luca, Leonardo, et al.
Publicado: (2021)

Antithrombotic and anticoagulation therapies in cardiogenic shock: a critical review of the published literature
por: Radu, Razvan I., et al.
Publicado: (2021)

Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2021)

Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
por: Koziński, Marek, et al.
Publicado: (2020)

Optimal Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Focused Review on High Bleeding Risk
por: Matsuura, Yunosuke, et al.
Publicado: (2022)

Clinical Pharmacokinetics and Pharmacodynamics of CSL112
por: Ortega-Paz, Luis, et al.
Publicado: (2023)

Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy?
por: Limbruno, Ugo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1gpggvuqn86olhcdpr59ii832k